The Annals Visit the PharmaCE website!
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 27, No. 3, pp. 298-301.
© 1993 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bertz, R.
Right arrow Articles by Howrie, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bertz, R.
Right arrow Articles by Howrie, D.

Research Articles

Diazepam by continuous intravenous infusion for status epilepticus in anticonvulsant hypersensitivity syndrome

RJ Bertz and DL Howrie

OBJECTIVE: To report a case of status epilepticus in a patient with anticonvulsant hypersensitivity syndrome (AHS) that was controlled successfully using continuous intravenous infusion diazepam. AHS and alternatives for treatment of status epilepticus are also reviewed. DESIGN: Single case report. SETTING: 217-bed children's university hospital. PATIENT: Four-year-old, 20-kg girl, diagnosed with idiopathic tonic-clonic epilepsy, who developed AHS to phenobarbital and phenytoin and status epilepticus unresponsive to lorazepam. RESULTS: Diazepam intravenous infusion at dosages titrated to 8 mg/h was used successfully to control seizures for eight days until signs and symptoms of AHS had resolved and maintenance therapy with valproic acid was started. CONCLUSIONS: Continuous intravenous infusion diazepam is a reasonable therapeutic choice for the management of status epilepticus in a patient with AHS when traditional therapy such as phenytoin and phenobarbital cannot be used.


This article has been cited by other articles:


Home page
 PediatricsHome page
M. C. Carroll, K. A. Yueng-Yue, N. B. Esterly, and B. A. Drolet
Drug-Induced Hypersensitivity Syndrome in Pediatric Patients
Pediatrics, August 1, 2001; 108(2): 485 - 492.
[Abstract] [Full Text]

Home page
 J Child NeurolHome page
D. L. Gilbert and T. A. Glauser
Complications and Costs of Treatment of Refractory Generalized Convulsive Status Epilepticus in Children
J Child Neurol, September 1, 1999; 14(9): 597 - 601.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
D. L. Gilbert, P. S. Gartside, and T. A. Glauser
Efficacy and Mortality in Treatment of Refractory Generalized Convulsive Status Epilepticus in Children: A Meta-Analysis
J Child Neurol, September 1, 1999; 14(9): 602 - 609.
[Abstract] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 1993 by Harvey Whitney Books Company.